Bronowicki Jean-Pierre, Bineau Catherine, Feugier Pierre, Hermine Olivier, Brousse Nicole, Oberti Frédéric, Rousselet Marie-Christine, Dharancy Sébastien, Gaulard Philippe, Flejou Jean-François, Cazals-Hatem Dominique, Labouyrie Eric
Department of Hépato-gastroentérologie, INSERM EMI 0014, CHU, Nancy,
Hepatology. 2003 Apr;37(4):781-7. doi: 10.1053/jhep.2003.50121.
Primary lymphoma of the liver (PLL) is rare. In some cases, the hepatic lymphoma has been diagnosed in patients who were infected by the hepatitis C virus (HCV). It has been suggested that HCV plays a role in the pathogenesis of lymphoma. The aim of our multicentric retrospective study was to assess the characteristics of PLL and to determine the prevalence of HCV infection in PLL. Thirty-one immunocompetent patients (anti-human immunodeficiency virus, anti-human T-cell leukemia/lymphoma virus negative, no history of allograft) with PLL fulfilled the entire selection criteria. The liver biopsy specimens were reassessed by the same pathologist. The non-Hodgkin's lymphomas were classified according to the World Health Organization classification. Blood samples were tested in 28 patients for antibodies to HCV, and HCV RNA was detected by reverse transcription polymerase chain reaction. In the majority of cases, the clinical, biologic, and radiologic data were nonspecific. Twenty-seven of 31 patients presented a B-cell lymphoma corresponding to the centroblastic morphologic variant of a diffuse, large B-cell lymphoma (22 cases), a Burkitt's lymphoma (1 case), an extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type (3 cases), and unclassified, small B-cell lymphoma (1 case). The 4 other cases were T-cell lymphomas. The prevalence of HCV infection was 21% (6 of 28 cases). All of these patients were positive for HCV RNA by polymerase chain reaction in blood. Most of the HCV-infected patients presented a high-grade, B-cell type lymphoma. In conclusion, our study confirms the rarity of PLL and demonstrates an increased prevalence of HCV infection.
原发性肝淋巴瘤(PLL)较为罕见。在某些情况下,丙型肝炎病毒(HCV)感染患者被诊断出患有肝淋巴瘤。有人提出HCV在淋巴瘤的发病机制中起作用。我们多中心回顾性研究的目的是评估PLL的特征,并确定PLL中HCV感染的患病率。31例免疫功能正常(抗人类免疫缺陷病毒、抗人类T细胞白血病/淋巴瘤病毒阴性,无同种异体移植史)的PLL患者符合全部入选标准。肝活检标本由同一位病理学家重新评估。非霍奇金淋巴瘤根据世界卫生组织分类进行分类。对28例患者的血样进行HCV抗体检测,并通过逆转录聚合酶链反应检测HCV RNA。在大多数情况下,临床、生物学和放射学数据均无特异性。31例患者中有27例表现为B细胞淋巴瘤,分别对应弥漫性大B细胞淋巴瘤的中心母细胞形态学变异型(22例)、伯基特淋巴瘤(1例)、黏膜相关淋巴组织型结外边缘区B细胞淋巴瘤(3例)和未分类的小B细胞淋巴瘤(1例)。其他4例为T细胞淋巴瘤。HCV感染的患病率为21%(28例中的6例)。所有这些患者血液中的HCV RNA通过聚合酶链反应检测均为阳性。大多数HCV感染患者表现为高级别B细胞型淋巴瘤。总之,我们的研究证实了PLL的罕见性,并表明HCV感染的患病率有所增加。